5 Key Takeaways

• 1

  The FDA approved Tryptyr for treating dry eye disease, marking it as a first-in-class TRPM8 receptor agonist that enhances natural tear production.

• 2

  Genentech's Susvimo received FDA approval for diabetic retinopathy, offering a continuous delivery system requiring treatment every 9 months.

• 3

  BVI Medical's Laser Endoscopy Ophthalmic System gained FDA clearance, aiming to lower intraocular pressure through a minimally invasive procedure.

• 4

  Johnson & Johnson launched Acuvue Oasys Max 1-Day Multifocal for Astigmatism, the first daily disposable lens for astigmatism and presbyopia.

• 5

  Luminopia's amblyopia treatment received FDA clearance for patients aged 8 to 12, marking the first approval for this age group in over 20 years.